Ben Zion Dolitzky

Head of R&D, TAPI Israel

​"There is no better school than Teva. This is a school for life."
Ben Zion Dolitzky
​Benzi joined Teva when he was just 17 years old, working for several months as an operator at the Assia site. He joined Teva again in 1993 after completing a Ph.D in organic chemistry at Tel Aviv University. "When I joined Teva,” he recalls, “there were about 40 researchers in R&D. Today there are about 200. I can really say that I grew up with TAPI R&D."
Benzi's initial role was as a chemical researcher at Plantex R&D. He followed this as a senior partner in the development of Teva’s flagship product, Copaxone. In 1994 he became troubleshooting manager, taking on responsibility for all Israeli manufactured products at the Plantex, Abic and Assia sites. In 2003, Benzi became head of chemical R&D. Today, he serves as the head of all TAPI Israel’s R&D activities.

"Daily work is challenging, unpredictable and brings great satisfaction,” relates Benzi. “The most important thing is to always be open to ideas, and to think outside the box without compromising product quality and regulatory requirements. As can be seen, TAPI R&D has become an important part of my life."

Benzi is known at Teva as one of the professional authorities on organic chemistry. This is complemented by many strong interpersonal relationships, and an ability to lead and promote excellence. "Organic chemistry is in my heart,” he says, “and I am happy to contribute to TEVA's success and to invest in the next generation of chemists."